Stamlo Trio 40/12.5 Tablet
By Stamlo Trio
Rx
15 Tablet in a Strip

Composition
Telmisartan(40mg) + Amlodipine(5mg) + Chlorthalidone(12.5mg)

Manufacturer - Dr Reddy's Laboratories Ltd
Dr. Reddy's Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, INDIA

Expires on or after
May, 2026

liver
When using Stamlo Trio 40/12.5 Tablet, caution is advised in individuals with liver disease. It may be necessary to adjust the dosage of the medication in such cases. Consulting your doctor before taking Stamlo Trio 40/12.5 Tablet is important, especially if you have any liver conditions. It is advised not to use this medication in patients with severe liver disease.

kidney
Stamlo Trio 40/12.5 Tablet should be used carefully in patients with severe kidney disease. Adjusting the dose may be necessary, so it's important to consult with your doctor. Avoid using this medication in such patients.

alcohol
When taking Stamlo Trio 40/12.5 Tablet, avoid consuming alcohol as it is considered unsafe to do so.

driving
Stamlo Trio 40/12.5 Tablet might lead to side effects like dizziness, headaches, nausea, or tiredness, impacting driving ability due to reduced focus and reaction time.

pregnancy
Stamlo Trio 40/12.5 Tablet is not safe to use during pregnancy due to potential risk to the developing baby. Use only if doctor prescribes in life-threatening situations with careful consideration of benefits versus risks. It is important to consult your doctor before use.

breastfeeding
Stamlo Trio 40/12.5 Tablet is considered safe during breastfeeding based on limited data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹181
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024